Related Experiment Video
Updated: Aug 13, 2026

The Tail Suspension Test
Published on: January 28, 2012
Lithium-induced changes in plasma amino acid levels during treatment of affective disorders
Abstract:
Plasma amino acid (AA) profiles were determined in patients with bipolar affective disorders before and during treatment with lithium (Li) carbonate. After 90 days of Li intake, there were moderately (20-60%) but significantly decreased plasma levels of isoleucine, leucine, and valine. After 150 days of Li intake, the plasma lysine was also significantly decreased (12%). No significant changes in plasma levels were noted for any of the other 17 AAs that were studied. Since isoleucine, leucine, and valine are important competitors of tryptophan uptake at the blood-brain barrier, these observations suggest a possible mechanism for the therapeutic activity of Li, i.e., the enhancement of brain serotonin levels.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Therapy
Antianxiety Medications

